Sign in to view content

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema

Victor Hugo Gonzalez, MD

Video
Published 2024

Related

New Data and Insights from Several DRCR.net Protocols
Lee Jampol, MD
Updates from the Field
2017
OCT Angiographic Metrics for Discriminating Diabetic Retinopathy Stages - Normalized Perfusion Deviation vs Perfusion Density vs FAZ Measurements
Richard B. Rosen, MD, DSc(Hon), FACS, FASRS, FARVO
On Demand Cases, Courses, and Papers
2019
Clinical Outcomes of Eyes with Diabetic Macular Edema Switched from Aflibercept to Ranibizumab Therapy
Michael A Klufas, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more